KFDA to delay final decision of IPA safety
The Korea Food and Drug Administration’s Central Pharmaceutical Deliberation Committee will finally assess the IPA safety issues after careful review of IPA related adverse events and usage in f...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
